ArticleGeriatrics & gerontology international2026
Clinical Characteristics and Prognosis of Thromboembolism in Elderly Patients With Stage IV Lung Cancer.
Article in Geriatrics & gerontology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comment on "Clinical Characteristics and Prognosis of Thromboembolism in Elderly Patients With Stage IV Lung Cancer".Geriatrics & gerontology international · 2026Article
- Risk factor analysis and prediction of lower-extremity deep vein thrombosis after surgery in patients with non-small cell lung cancer.Frontiers in oncology · 2026Article
- Clinical Characteristics and Prognosis of Thromboembolism in Elderly Patients With Stage IV Lung Cancer.Geriatrics & gerontology international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLung cancer is associated with a high risk of thromboembolism. The incidence and mortality of lung cancer increased in the population over 60 years old. Our research aimed to reveal the risk factors and prognosis of thromboembolism in elderly patients with stage IV lung cancer.
methodsMetastatic lung cancer patients over 60 years of age at the Affiliated Jiangyin Hospital of Nantong University between 1 January 2011 and 30 June 2019 were screened. Univariable and multivariable analyses were conducted to reveal the risk factors for thromboembolism. Log-rank test and multivariate Cox regression analysis were performed to determine the prognosis of this cohort.
resultsFour hundred and fourteen-patients included in this study, 33 developed venous thromboembolism (VTE), and 39 developed arterial thromboembolism (ATE), respectively. Body mass index (BMI) and D-dimer level were independent risk factors associated with VTE. History of hypertension was an independent risk factor related to ATE. Older patients with ATE were associated with shorter overall survival (OS) of 7 months.
conclusionsHigher levels of BMI and D-dimer were related to VTE, while hypertension was related to ATE. ATE was associated with a poorer prognosis. In clinical practice, appropriate prevention and treatment of thromboembolism should be conducted in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.